Aortic Regurgitation in 2022 - Undertreatment, Timing of Intervention, TAVR and Future Evidence Needs

James M. McCabe, Vinod H. Thourani, Nadira Hamid, Ravi Ramana and Mark J. Russo discuss JenaValve’s Trilogy System as a solution for severe AR patients at the “Aortic Regurgitation in 2022 – Undertreatment, Timing of Intervention, TAVR and Future Evidence Needs” symposium.